Literature DB >> 23106594

Cross-linking protein glutathionylation mediated by O2-arylated bis-diazeniumdiolate "Double JS-K".

Ryan J Holland1, Anna E Maciag, Varun Kumar, Lei Shi, Joseph E Saavedra, Robert K Prud'homme, Harinath Chakrapani, Larry K Keefer.   

Abstract

Attachment of glutathione (GSH) to cysteine residues in proteins (S-glutathionylation) is a reversible post-translational modification that can profoundly alter protein structure and function. Often serving in a protective role, for example, by temporarily saving protein thiols from irreversible oxidation and inactivation, glutathionylation can be identified and semiquantitatively assessed using anti-GSH antibodies, thought to be specific for recognition of the S-glutathionylation modification. Here, we describe an alternate mechanism of protein glutathionylation in which the sulfur atoms of the GSH and the protein's thiol group are covalently bound via a cross-linking agent, rather than through a disulfide bond. This form of thiol cross-linking has been shown to occur and has been confirmed by mass spectrometry at the solution chemistry level, as well as in experiments documenting the potent antiproliferative activity of the bis-diazeniumdiolate Double JS-K in H1703 cells in vitro and in vivo. The modification is recognized by the anti-GSH antibody as if it were authentic S-glutathionylation, requiring mass spectrometry to distinguish between them.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23106594      PMCID: PMC3524378          DOI: 10.1021/tx3003142

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  20 in total

1.  The secondary amine/nitric oxide complex ion R(2)N[N(O)NO](-) as nucleophile and leaving group in S9N)Ar reactions.

Authors:  J E Saavedra; A Srinivasan; C L Bonifant; J Chu; A P Shanklin; J L Flippen-Anderson; W G Rice; J A Turpin; K M Davies; L K Keefer
Journal:  J Org Chem       Date:  2001-05-04       Impact factor: 4.354

Review 2.  Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.

Authors:  Satish K Srivastava; Kota V Ramana; Aruni Bhatnagar
Journal:  Endocr Rev       Date:  2005-04-06       Impact factor: 19.871

3.  Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta.

Authors:  Niki L Reynaert; Albert van der Vliet; Amy S Guala; Toby McGovern; Milena Hristova; Cristen Pantano; Nicholas H Heintz; John Heim; Ye-Shih Ho; Dwight E Matthews; Emiel F M Wouters; Yvonne M W Janssen-Heininger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

4.  Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivo.

Authors:  Paul J Shami; Joseph E Saavedra; Challice L Bonifant; Jingxi Chu; Vidya Udupi; Swati Malaviya; Brian I Carr; Siddhartha Kar; Meifeng Wang; Lee Jia; Xinhua Ji; Larry K Keefer
Journal:  J Med Chem       Date:  2006-07-13       Impact factor: 7.446

5.  A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins.

Authors:  Danyelle M Townsend; Victoria J Findlay; Farit Fazilev; Molly Ogle; Jacob Fraser; Joseph E Saavedra; Xinhua Ji; Larry K Keefer; Kenneth D Tew
Journal:  Mol Pharmacol       Date:  2005-11-15       Impact factor: 4.436

6.  JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity.

Authors:  Paul J Shami; Joseph E Saavedra; Lai Y Wang; Challice L Bonifant; Bhalchandra A Diwan; Shivendra V Singh; Yijun Gu; Stephen D Fox; Gregory S Buzard; Michael L Citro; David J Waterhouse; Keith M Davies; Xinhua Ji; Larry K Keefer
Journal:  Mol Cancer Ther       Date:  2003-04       Impact factor: 6.261

7.  JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells.

Authors:  Tanyel Kiziltepe; Teru Hideshima; Kenji Ishitsuka; Enrique M Ocio; Noopur Raje; Laurence Catley; Chun-Qi Li; Laura J Trudel; Hiroshi Yasui; Sonia Vallet; Jeffery L Kutok; Dharminder Chauhan; Constantine S Mitsiades; Joseph E Saavedra; Gerald N Wogan; Larry K Keefer; Paul J Shami; Kenneth C Anderson
Journal:  Blood       Date:  2007-03-23       Impact factor: 22.113

8.  JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas.

Authors:  Astrid Weyerbrock; Nadja Osterberg; Nikolaos Psarras; Brunhilde Baumer; Evangelos Kogias; Anna Werres; Stefanie Bette; Joseph E Saavedra; Larry K Keefer; Anna Papazoglou
Journal:  Neurosurgery       Date:  2012-02       Impact factor: 4.654

9.  Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes.

Authors:  A Eastman
Journal:  Chem Biol Interact       Date:  1987-03       Impact factor: 5.192

10.  Stable and controllable RNA interference: Investigating the physiological function of glutathionylated actin.

Authors:  Jun Wang; Ephrem Tekle; Hammou Oubrahim; John J Mieyal; Earl R Stadtman; P Boon Chock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

View more
  2 in total

1.  A comparison of reversible versus irreversible protein glutathionylation.

Authors:  Danyelle M Townsend; Volodymyr I Lushchak; Arthur J L Cooper
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

2.  Nitric oxide (NO) releasing poly ADP-ribose polymerase 1 (PARP-1) inhibitors targeted to glutathione S-transferase P1-overexpressing cancer cells.

Authors:  Anna E Maciag; Ryan J Holland; Youseung Kim; Vandana Kumari; Christina E Luthers; Waheed S Sehareen; Debanjan Biswas; Nicole L Morris; Xinhua Ji; Lucy M Anderson; Joseph E Saavedra; Larry K Keefer
Journal:  J Med Chem       Date:  2014-02-25       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.